EUVIMEDEUVIMED entdecken
Open Access

Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review

Hee Jun Shin, Ik Tae Cho, Wan Suk Choi, Hong Rae Kim, Min Bong Kang, Won Jong Yang

Journal of Yeungnam Medical Science · 18.11.2024 · 42 · 8

DOI: 10.12701/jyms.2024.01004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Yeungnam Medical Science, online erschienen am 18.11.2024. Verfasst von Hee Jun Shin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Therapy, Kyungwoon University, Gumi, Korea. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kyungwoon University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Digital therapeutics (DTx) are emerging as a transformative innovation in healthcare offering evidence-based digital interventions for the treatment, management, and prevention of various diseases and disorders. In Korea, DTx have gained significant attention as potential solutions to the increasing burden of chronic diseases and mental health conditions. However, the Korean DTx market faces several challenges that hinder its widespread adoption and integration into the national healthcare system. This study provides a comprehensive analysis of the current state of the DTx market in Korea, identifies the key challenges impeding its growth, and proposes strategies for overcoming these obstacles. This study utilized a literature review and market analysis approach to examine the latest research, industry reports, and regulatory documents related to DTx. The analysis focused on three primary areas: (1) the current regulatory landscape, (2) technological advancements and challenges, and (3) economic and commercial factors influencing DTx adoption in Korea. A comparative analysis of global regulatory practices was also conducted to identify best practices. The findings revealed that while Korea has made significant strides in supporting DTx development, the market remains in its early stages. The key challenges include underdeveloped regulatory frameworks, issues with data quality and security, and a lack of established reimbursement pathways. We recommend developing tailored regulatory frameworks for DTx, enhancing policy support for small and medium-sized enterprises involved in DTx development, and increasing investments in technological infrastructure. By addressing these challenges, Korea could position itself as a leader in the global DTx market, delivering innovative and effective treatments to enhance patient care and outcomes.

Schlagwörter

Stichwörter der Autor:innen

Chronic diseaseHealth care economics and organizationsHealth policyTechnology assessmentTelemedicine

Autor:innen und Institutionen

  • Department of Physical Therapy, Kyungwoon University, Gumi, Korea.
  • Department of Physical Medicine and Rehabilitation, Daegu Medical Foundation K Hospital, Daegu, Korea.
  • Department of Physical Therapy, Musculoskeletal Center, Daegu Medical Foundation K Hospital, Daegu, Korea.

Förderung

  • Kyungwoon University

Zitieren

APA

Shin, H. J., Cho, I. T., Choi, W. S., Kim, H. R., Kang, M. B., & Yang, W. J. (2024). Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review. Journal of Yeungnam Medical Science, 42, 8. https://doi.org/10.12701/jyms.2024.01004

Vancouver

Shin HJ, Cho IT, Choi WS, Kim HR, Kang MB, Yang WJ. Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review. Journal of Yeungnam Medical Science. 2024;42:8. doi:10.12701/jyms.2024.01004

BibTeX
@article{Shin2024,
  author = {Shin, Hee Jun and Cho, Ik Tae and Choi, Wan Suk and Kim, Hong Rae and Kang, Min Bong and Yang, Won Jong},
  title = {Digital therapeutics in Korea: current status, challenges, and future directions – a narrative review},
  journal = {Journal of Yeungnam Medical Science},
  year = {2024},
  volume = {42},
  pages = {8},
  doi = {10.12701/jyms.2024.01004}
}
Kostenlos starten →